A pharma company based in Belgium with a product for the treatment of cancer.
In the context of a reimbursement dossier, our client had to estimate the number of patients that are potential candidates for a new medication (rare mutation).
Our experts: Project manager, Data manager, CRA, Writer and Statistician
Our clinical team designed and conducted a retrospective study with the support of 20 healthcare centers (laboratory and/or oncology departments) in Belgium.
Results / added value:
Within the 6-months deadline, our teams were able to conduct a retrospective data collection study and prepare the report. Our client was able to identify potential patients and the responsible physicians. Our client was able to submit the complete request in time.